eFT508

Overview
Catalog #	bs-83375c-25mg
Product Name	eFT508
Specifications
Storage Buffer	Pale yellow solid
Storage Condition	-20°C
Target
Product Information	eFT508 is a potent (IC50s = 2.4 nM MNK1; 1.0 nM MNK2) and highly selective inhibitor of the mitogen-activated protein kinase interacting kinases 1 and 2 (MNK1/2), key regulators of mRNA translation protein eukaryotic initiation factor eIF4E.1 It potently inhibits phosphorylation of eIF4E in multiple solid and hematological tumor lines leading to blockade of pro-inflammatory and pro-tumorigenic cytokine production. eFT508 reversed the aggressive and metastatic characteristics of mouse liver cancer via inhibition of PD-L1 upregulation.2 Displays inhibitory effects in various cancers models including acute myeloid leukemia3, gastric4, and breast5. eFT-508 has also shown efficacy in treating neuropathic pain via the MNK-eIF4E pathway.6,7,8
Description	CAS Number: 1849590-01-7 Chemical Name: Potent MNK1/2 inhibitor Molecular Weight: 340.39 Formula: C17H20N6O2 Solubility: DMSO (2 mg/ml with warming) Physical Properties: Pale yellow solid Purity: 98% by HPLC NMR (Conforms)